Literature DB >> 27234231

STAT4 rs7574865 G/T polymorphism is associated with rheumatoid arthritis and disease activity, but not with anti-CCP antibody levels in a Mexican population.

Ma de Jesús Durán-Avelar1, Norberto Vibanco-Pérez1, Raquel Rocío Hernández-Pacheco2, América Del Carmen Castro-Zambrano1, Liliana Ortiz-Martínez3, José Francisco Zambrano-Zaragoza4.   

Abstract

Rheumatoid arthritis (RA) is a systemic autoimmune disease in whose etiology genetic factors are known to play an important role. Among the genes associated with RA, STAT4 could be an important factor in conducting helper T cells toward the pro-inflammatory Th1 and Th17 lineages. The aim of this study is to determine the association of the STAT4 polymorphism rs7574865 with RA, disease activity, and anti-cyclic citrullinated peptide (CCP) antibody levels in a Mexican population. Genotyping was carried out using the Taqman® system from Applied Biosystems in 140 patients with RA and 150 healthy subjects. Disease activity was evaluated by a rheumatologist using the DAS28 and Spanish-HAQ-DI instruments. Anti-CCP levels were determined by ELISA. Associations of the genotypes of rs7574865 with DAS28, HAQ, and anti-CCP antibody levels with RA were determined. Findings showed that the GT and TT genotypes and the T allele from rs7574865 were all associated as risk factors for RA, independently of their anti-CCP status. An association with moderate-to-high disease activity (DAS28 ≥ 3.2) was also found. Additionally, patients with the GT or TT genotypes showed lower HAQ values than those who carried the GG genotype. No differences in anti-CCP antibody levels or DAS28 and genotypes were found. This work supports the association of the STAT4 rs7574865 polymorphism with RA and disease activity, but not with anti-CCP antibody levels in a Mexican population.

Entities:  

Keywords:  Biomarkers; Case–control study; Polymorphism; Rheumatoid arthritis; SNP

Mesh:

Substances:

Year:  2016        PMID: 27234231     DOI: 10.1007/s10067-016-3320-z

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  30 in total

1.  2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Authors:  Daniel Aletaha; Tuhina Neogi; Alan J Silman; Julia Funovits; David T Felson; Clifton O Bingham; Neal S Birnbaum; Gerd R Burmester; Vivian P Bykerk; Marc D Cohen; Bernard Combe; Karen H Costenbader; Maxime Dougados; Paul Emery; Gianfranco Ferraccioli; Johanna M W Hazes; Kathryn Hobbs; Tom W J Huizinga; Arthur Kavanaugh; Jonathan Kay; Tore K Kvien; Timothy Laing; Philip Mease; Henri A Ménard; Larry W Moreland; Raymond L Naden; Theodore Pincus; Josef S Smolen; Ewa Stanislawska-Biernat; Deborah Symmons; Paul P Tak; Katherine S Upchurch; Jirí Vencovsky; Frederick Wolfe; Gillian Hawker
Journal:  Ann Rheum Dis       Date:  2010-09       Impact factor: 19.103

2.  Signal transducer and activator of transcription and the risk of rheumatoid arthritis and thyroid autoimmune disorders.

Authors:  M Ben Hamad; F Cornelis; H Mbarek; G Chabchoub; S Marzouk; Z Bahloul; A Rebai; F Fakhfakh; H Ayadi; E Petit-Teixeira; A Maalej
Journal:  Clin Exp Rheumatol       Date:  2011-04-19       Impact factor: 4.473

3.  Association of PTPN22 rs2476601 and STAT4 rs7574865 polymorphisms with rheumatoid arthritis: A meta-analysis update.

Authors:  Rami Elshazli; Ahmad Settin
Journal:  Immunobiology       Date:  2015-04-28       Impact factor: 3.144

4.  Influence of TRAF1/C5 and STAT4 genes polymorphisms on susceptibility and severity of rheumatoid arthritis in Egyptian population.

Authors:  Rasha H Mohamed; Heba F Pasha; Eman E El-Shahawy
Journal:  Cell Immunol       Date:  2011-12-04       Impact factor: 4.868

5.  High anti-CCP antibody titres predict good response to rituximab in patients with active rheumatoid arthritis.

Authors:  Anaïs Gardette; Sébastien Ottaviani; Florence Tubach; Carine Roy; Pascale Nicaise-Roland; Elisabeth Palazzo; Ghislaine Gill; Olivier Meyer; Philippe Dieudé
Journal:  Joint Bone Spine       Date:  2014-07-03       Impact factor: 4.929

6.  Association of STAT4 with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in the Japanese population.

Authors:  Shu Kobayashi; Katsunori Ikari; Hirotaka Kaneko; Yuta Kochi; Kazuhiko Yamamoto; Kenichi Shimane; Yusuke Nakamura; Yoshiaki Toyama; Takeshi Mochizuki; So Tsukahara; Yasushi Kawaguchi; Chihiro Terai; Masako Hara; Taisuke Tomatsu; Hisashi Yamanaka; Takahiko Horiuchi; Kayoko Tao; Koji Yasutomo; Daisuke Hamada; Natsuo Yasui; Hiroshi Inoue; Mitsuo Itakura; Hiroshi Okamoto; Naoyuki Kamatani; Shigeki Momohara
Journal:  Arthritis Rheum       Date:  2008-07

Review 7.  STAT4: genetics, mechanisms, and implications for autoimmunity.

Authors:  Benjamin D Korman; Daniel L Kastner; Peter K Gregersen; Elaine F Remmers
Journal:  Curr Allergy Asthma Rep       Date:  2008-09       Impact factor: 4.806

8.  STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk.

Authors:  A-K Abelson; A M Delgado-Vega; S V Kozyrev; E Sánchez; R Velázquez-Cruz; N Eriksson; J Wojcik; M V P Linga Reddy; G Lima; S D'Alfonso; S Migliaresi; V Baca; L Orozco; T Witte; N Ortego-Centeno; H Abderrahim; B A Pons-Estel; C Gutiérrez; A Suárez; M F González-Escribano; J Martin; M E Alarcón-Riquelme
Journal:  Ann Rheum Dis       Date:  2008-11-19       Impact factor: 19.103

Review 9.  Th17 cells in autoimmune and infectious diseases.

Authors:  José Francisco Zambrano-Zaragoza; Enrique Jhonatan Romo-Martínez; Ma de Jesús Durán-Avelar; Noemí García-Magallanes; Norberto Vibanco-Pérez
Journal:  Int J Inflam       Date:  2014-08-03

10.  Serum RANKL levels associate with anti- citrullinated protein antibodies in early untreated rheumatoid arthritis and are modulated following methotrexate.

Authors:  Aase Haj Hensvold; Vijay Joshua; Wanying Li; Michaela Larkin; Ferhan Qureshi; Lena Israelsson; Leonid Padyukov; Karin Lundberg; Nadine Defranoux; Saedis Saevarsdottir; Anca Irinel Catrina
Journal:  Arthritis Res Ther       Date:  2015-09-04       Impact factor: 5.156

View more
  3 in total

1.  The TNFA -857C/T Polymorphism: Association with Rheumatoid Arthritis and Anti-CCP Levels in a Mexican Population.

Authors:  Juan Manuel Agraz-Cibrián; Gabriela Nohemí Espinoza-De León; Ma de Jesús Durán-Avelar; Norberto Vibanco-Pérez; Liliana Ortiz-Martínez; Alejandro Vázquez-Reyes; Jorge Gutiérrez-Franco; Miriam Fabiola Ayón-Pérez; José Francisco Zambrano-Zaragoza
Journal:  J Immunol Res       Date:  2019-10-09       Impact factor: 4.818

2.  The influence of the -94 Ins/Del ATTG polymorphism of NFkB on the anti-CCP antibody levels in patients with rheumatoid arthritis.

Authors:  Miriam Fabiola Ayón-Pérez; Jonathan Joseph Topete-Córdoba; Juan Manuel Agraz-Cibrián; Liliana Ortiz-Martínez; Ma de Jesús Durán-Avelar; Alejandro Vázquez-Reyes; Norberto Vibanco-Pérez; Jorge Gutiérrez-Franco; José Francisco Zambrano-Zaragoza
Journal:  Medicine (Baltimore)       Date:  2021-12-17       Impact factor: 1.817

3.  Increased Risk of Thyroid Dysfunction Among Patients With Rheumatoid Arthritis.

Authors:  Qian Li; Bin Wang; Kaida Mu; Jing Zhang; Yanping Yang; Wei Yao; Jie Zhu; Jin-An Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2019-01-11       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.